Gilead files U.S. marketing application for remdesivir

By Syndicated Content Aug 10, 2020 | 10:12 AM

(Reuters) – Gilead Sciences Inc said on Monday it has filed a marketing application with the U.S. Food and Drug Administration for its experimental COVID-19 drug remdesivir.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)